Education
About Us
Working with TipRanks
Follow Us
PuraPharm Corp. Ltd. (HK:1498)
:1498
RESEARCH TOOLSreports
Total Valuation
PuraPharm Corp. Ltd. has a market cap or net worth of HK$189.57M. The enterprise value is HK$901.21M.
Market CapHK$189.57M
Enterprise ValueHK$901.21M
Share Statistics
PuraPharm Corp. Ltd. has 395,897,280 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding395,897,280
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PuraPharm Corp. Ltd.’s return on equity (ROE) is -0.32 and return on invested capital (ROIC) is -7.33%.
Return on Equity (ROE)-0.32
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-7.33%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee797.68K
Profits Per Employee-73.99K
Employee Count479
Asset Turnover0.53
Inventory Turnover1.43
Valuation Ratios
The current PE Ratio of PuraPharm Corp. Ltd. is -6.13. PuraPharm Corp. Ltd.’s PEG ratio is 1.30.
PE Ratio-6.13
PS Ratio0.00
PB Ratio1.96
Price to Fair Value1.95
Price to FCF11.94
Price to Operating Cash Flow7.67
PEG Ratio1.30
Income Statement
In the last 12 months, PuraPharm Corp. Ltd. had revenue of 382.09M and earned -35.44M in profits. Earnings per share was -0.09.
Revenue382.09M
Gross Profit205.14M
Operating Income-29.41M
Pretax Income-28.83M
Net Income-35.44M
EBITDA17.35M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was 103.98M and capital expenditures -14.81M, giving a free cash flow of 89.18M billion.
Operating Cash Flow103.98M
Free Cash Flow89.18M
Free Cash Flow per Share0.23
Dividends & Yields
PuraPharm Corp. Ltd. pays an annual dividend of HK$0.02, resulting in a dividend yield of ―
Dividend Per ShareHK$0.02
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.33
52-Week Price Change-34.25%
50-Day Moving Average0.50
200-Day Moving Average0.59
Relative Strength Index (RSI)41.85
Average Volume (3m)54.56K
Important Dates
PuraPharm Corp. Ltd. upcoming earnings date is Sep 2, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend DateMay 31, 2017
Financial Position
PuraPharm Corp. Ltd. as a current ratio of 0.55, with Debt / Equity ratio of 194.80%
Current Ratio0.55
Quick Ratio0.30
Debt to Market Cap1.56
Net Debt to EBITDA20.23
Interest Coverage Ratio0.00
Taxes
In the past 12 months, PuraPharm Corp. Ltd. has paid 6.29M in taxes.
Income Tax6.29M
Effective Tax Rate-0.22
Enterprise Valuation
PuraPharm Corp. Ltd. EV to EBITDA ratio is 32.76, with an EV/FCF ratio of 6.37.
EV to Sales1.49
EV to EBITDA32.76
EV to Free Cash Flow6.37
EV to Operating Cash Flow5.46
Balance Sheet
PuraPharm Corp. Ltd. has HK$12.79M in cash and marketable securities with HK$363.76M in debt, giving a net cash position of HK$350.96M billion.
Cash & Marketable SecuritiesHK$12.79M
Total DebtHK$363.76M
Net CashHK$350.96M
Net Cash Per ShareHK$0.89
Tangible Book Value Per ShareHK$0.16
Margins
Gross margin is 58.16%, with operating margin of -7.70%, and net profit margin of -9.28%.
Gross Margin58.16%
Operating Margin-7.70%
Pretax Margin-7.55%
Net Profit Margin-9.28%
EBITDA Margin4.54%
EBIT Margin-4.78%
Analyst Forecast
The average price target for PuraPharm Corp. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-6.09%
EPS Growth Forecast66.59%